•  
  •  
  •  
  •  

2025-12-23 14:22:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  INE694N01015

Stock Report

  • Heranba Organics Pvt Ltd commences Commercial Production at its Sarigam Unit, Phase-II
  • Heranba Organics Pvt Ltd commences Commercial Production at its Saykha Unit
  • Heranba Organics Pvt Ltd commences Commercial Production at its Sarigam Unit
  • Heranba Industries Limited Reports Q3FY24 Results
  • GPCB revokes closure order issued to Heranba Industries Ltd's Vapi Plant Unit-1
  • Heranba Industries Limited receives six CIB registrations
  • Heranba Industries Ltd recommends final dividend of Rs. 2
  • Heranba Industries to set up subsidiary Mikusu India Pvt Ltd
  • Heranba Industries acquires additional Industrial Plot at Saykha Industrial Estate for expansion
  • Heranba Industries commences Commercial Production at its new Unit-IV
  • Heranba Industries Limited Reports Q2FY22 Results

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024